SCOPUS 정보 검색 플랫폼

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 876, Issue 2, 2008, Pages 182-190

Evaluation of preparative high performance liquid chromatography and cryoprobe-nuclear magnetic resonance spectroscopy for the early quantitative estimation of drug metabolites in human plasma

(4) Dear, G J a Roberts, A D a Beaumont, C a North, S E a

a Structural ID Group (United Kingdom)

Author keywords

Human plasma; Metabolites; NMR; Preparative HPLC; Quantification

Indexed keywords

ANIMAL CELL CULTURE; ATOMS; BIOCHEMISTRY; BIOMOLECULES; BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; MAGNETIC RESONANCE; MAGNETIC RESONANCE SPECTROMETERS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLITES; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE DETECTORS; PLASMA (HUMAN); PLASMAS; RESONANCE;

CLINICAL DEVELOPMENTS; CLINICAL STUDIES; DEVELOPMENT PROCESSES; DRUG CANDIDATES; DRUG METABOLITES; HUMAN PLASMA; HUMAN PLASMAS; IN PHASE; NMR; PHASE I; PREPARATIVE HPLC; PROOF OF CONCEPTS; QUANTIFICATION; QUANTITATIVE ESTIMATIONS;

LIQUID CHROMATOGRAPHY;

DRUG METABOLITE;

ARTICLE; CALIBRATION; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG TOLERABILITY; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; NITROGEN NUCLEAR MAGNETIC RESONANCE; NORMAL HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CLINICAL TRIALS, PHASE I AS TOPIC; DRUG MONITORING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PHARMACEUTICAL PREPARATIONS;

EID: 56549113149 PISSN: 15700232 EISSN: None Source Type: Journal
DOI: 10.1016/j.jchromb.2008.10.040 Document Type: Article

Times cited : (50)

References (24)

1
- 4143147349
- Fura A., Shu Y.Z., Zhu M., Hanson R.L., Roontga V., and Humphreys W.G. J. Med. Chem. 47 (2004) 4339
- (2004) J. Med. Chem. , vol.47 , pp. 4339
- Fura, A.¹ Shu, Y.Z.² Zhu, M.³ Hanson, R.L.⁴ Roontga, V.⁵ Humphreys, W.G.⁶

2
- 24644440657
- Park K., Williams D.P., Naisbitt D.J., Kitteringham N.R., and Pirohamed M. Toxicol. Appl. Pharmacol. 207 (2005) S425
- (2005) Toxicol. Appl. Pharmacol. , vol.207
- Park, K.¹ Williams, D.P.² Naisbitt, D.J.³ Kitteringham, N.R.⁴ Pirohamed, M.⁵

3
- 12544251868
- Shah R. Expert Opin. Drug Saf. 4 (2005) 103
- (2005) Expert Opin. Drug Saf. , vol.4 , pp. 103
- Shah, R.¹

4
- 56549101422
- Food and Drug Administration (Revised April 2005), Code of Federal Regulations 21CFR361.1 Radioactive drugs for certain research uses, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFR.Search.cfm (accessed January 17, 2006).
- Food and Drug Administration (Revised April 2005), Code of Federal Regulations 21CFR361.1 Radioactive drugs for certain research uses, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFR.Search.cfm (accessed January 17, 2006).

5
- 23244457383
- Anderson L.W., Collins J.M., Klecker R.W., Katki A.G., Parchment R.E., Boinpally R.R., LoRusso P.M., and Ivy S.P. Cancer Chemother. Pharmacol. 56 (2005) 351
- (2005) Cancer Chemother. Pharmacol. , vol.56 , pp. 351
- Anderson, L.W.¹ Collins, J.M.² Klecker, R.W.³ Katki, A.G.⁴ Parchment, R.E.⁵ Boinpally, R.R.⁶ LoRusso, P.M.⁷ Ivy, S.P.⁸

6
- 0032952578
- Plumb R.S., Ayrton J., Dear G.J., Sweatman B.C., and Ismail I.M. Rapid Commun. Mass Spectrom. 13 (1999) 845
- (1999) Rapid Commun. Mass Spectrom. , vol.13 , pp. 845
- Plumb, R.S.¹ Ayrton, J.² Dear, G.J.³ Sweatman, B.C.⁴ Ismail, I.M.⁵

7
- 0036842822
- Desmoulin F., Gilard V., Malet-Martino M., and Martino R. Drug Metab. Dispos. 30 (2002) 1221
- (2002) Drug Metab. Dispos. , vol.30 , pp. 1221
- Desmoulin, F.¹ Gilard, V.² Malet-Martino, M.³ Martino, R.⁴

8
- 0034055226
- Dear G.J., Ismail I.M., Mutch P.J., Plumb R.S., Davies L.H., and Sweatman B.C. Xenobiotica 30 (2000) 407
- (2000) Xenobiotica , vol.30 , pp. 407
- Dear, G.J.¹ Ismail, I.M.² Mutch, P.J.³ Plumb, R.S.⁴ Davies, L.H.⁵ Sweatman, B.C.⁶

9
- 33644688432
- Malet-Martino M., Gilard V., Desmoulin F., and Martino R. Clin. Chim. Acta 366 (2006) 61
- (2006) Clin. Chim. Acta , vol.366 , pp. 61
- Malet-Martino, M.¹ Gilard, V.² Desmoulin, F.³ Martino, R.⁴

10
- 23644446181
- Malz F., and Jancke H. J. Pharma. Biomed. 38 (2005) 813
- (2005) J. Pharma. Biomed. , vol.38 , pp. 813
- Malz, F.¹ Jancke, H.²

11
- 18644385994
- Baillie T.A., Cayen M.N., Fouda H., Gerson R.J., Green J.D., Grossman S.J., Klunk L.J., LeBlanc B., Perkins D.G., and Shipley L.A. Toxicol. Appl. Pharmacol. 182 (2002) 188
- (2002) Toxicol. Appl. Pharmacol. , vol.182 , pp. 188
- Baillie, T.A.¹ Cayen, M.N.² Fouda, H.³ Gerson, R.J.⁴ Green, J.D.⁵ Grossman, S.J.⁶ Klunk, L.J.⁷ LeBlanc, B.⁸ Perkins, D.G.⁹ Shipley, L.A.¹⁰

12
- 0038162231
- Hastings K.L., El-Hage J., Jacobs A., Leighton J., Morse D., and Osterberg R.E. Toxicol. Appl. Pharmacol. 190 (2003) 91
- (2003) Toxicol. Appl. Pharmacol. , vol.190 , pp. 91
- Hastings, K.L.¹ El-Hage, J.² Jacobs, A.³ Leighton, J.⁴ Morse, D.⁵ Osterberg, R.E.⁶

13
- 24944563781
- Smith D.A., and Obach R.S. Drug Metab. Dispos. 33 (2005) 1409
- (2005) Drug Metab. Dispos. , vol.33 , pp. 1409
- Smith, D.A.¹ Obach, R.S.²

14
- 47649088457
- Luffer-Atlas D. Drug Met. Rev. 40 (2008) 447
- (2008) Drug Met. Rev. , vol.40 , pp. 447
- Luffer-Atlas, D.¹

15
- 56549102899
- Food and Drug Administration, Guidance for Industry: Safety Testing of Drug Metabolites, http://www.fda.gov/CDER/GUIDANCE/6897fnl.pdf (accessed 5 August 2008).
- Food and Drug Administration, Guidance for Industry: Safety Testing of Drug Metabolites, http://www.fda.gov/CDER/GUIDANCE/6897fnl.pdf (accessed 5 August 2008).

16
- 0032559168
- Dear G.J., Fraser I.J., Patel D.K., Long J., and Pleasance S. J. Chromatogr. A 794 (1998) 27
- (1998) J. Chromatogr. A , vol.794 , pp. 27
- Dear, G.J.¹ Fraser, I.J.² Patel, D.K.³ Long, J.⁴ Pleasance, S.⁵

17
- 0033926938
- Kebarle P. J. Mass Spectrom. 35 (2000) 804
- (2000) J. Mass Spectrom. , vol.35 , pp. 804
- Kebarle, P.¹

18
- 0036707428
- Keun H.C., Beckonert O., Griffin J.L., Richter C., Moskau D., Lindon J.C., and Nicholson J.K. Anal. Chem. 74 (2002) 4588
- (2002) Anal. Chem. , vol.74 , pp. 4588
- Keun, H.C.¹ Beckonert, O.² Griffin, J.L.³ Richter, C.⁴ Moskau, D.⁵ Lindon, J.C.⁶ Nicholson, J.K.⁷

19
- 0038817450
- Spraul M., Freund A.S., Nast R.E., Withers R.S., Maas W.E., and Corcoran O. Anal. Chem. 75 (2003) 1546
- (2003) Anal. Chem. , vol.75 , pp. 1546
- Spraul, M.¹ Freund, A.S.² Nast, R.E.³ Withers, R.S.⁴ Maas, W.E.⁵ Corcoran, O.⁶

20
- 0031873679
- Hop C.E.C.A., Wang Z., Chen Q., and Kwei G. J. Pharm. Sci. 87 (1998) 901
- (1998) J. Pharm. Sci. , vol.87 , pp. 901
- Hop, C.E.C.A.¹ Wang, Z.² Chen, Q.³ Kwei, G.⁴

21
- 56549115844
- G.J. Dear, U. Huber, Agilent Technologies Application note, publication number 5989-2089EN, 2004.
- G.J. Dear, U. Huber, Agilent Technologies Application note, publication number 5989-2089EN, 2004.

22
- 0023628652
- Wilson I.D., and Nicholson J.K. Anal. Chem. 59 (1987 2830)
- (1987) Anal. Chem. , vol.59
- Wilson, I.D.¹ Nicholson, J.K.²

23
- 0034997537
- Schaber G., Wiatr G., Wachsmuth H., Dachtler M., Albert K., Gaertner I., and Breyer-Pfaff U. Drug Metab. Dispos. 29 6 (2001) 923
- (2001) Drug Metab. Dispos. , vol.29 , Issue.6 , pp. 923
- Schaber, G.¹ Wiatr, G.² Wachsmuth, H.³ Dachtler, M.⁴ Albert, K.⁵ Gaertner, I.⁶ Breyer-Pfaff, U.⁷

24
- 0000160422
- Spraul M., Hofmann M., Ackermann M., Nicholls A.W., Damment S.J.P., Haselden J.N., Shocker J.P., Nicholson J.K., and Lindon J.C. Anal. Commun. 34 (1997) 339
- (1997) Anal. Commun. , vol.34 , pp. 339
- Spraul, M.¹ Hofmann, M.² Ackermann, M.³ Nicholls, A.W.⁴ Damment, S.J.P.⁵ Haselden, J.N.⁶ Shocker, J.P.⁷ Nicholson, J.K.⁸ Lindon, J.C.⁹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.